Tuesday, January 05, 2021 7:55:45 AM
We are here because the product was one of only a few similar, and there seemed to be early traction and excitement.
Fast forward....we are all extremely frustrated with progress/lack of.
However, in our gamble, what I think many are missing is that this could SKYROCKET with the right deal or two, and only one or two needed, for the Pharm investor mass to notice and decide to spec. It could be at $5 overnight, and IF.....IF we can get some distribution and revenue coming, that is but a mere ladder rung.
Yet, we don't that deal now, still just a dream. But it can happen fast if we can get a little momentum.
For sure, more patience required. It seems many have none left.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM